Docetaxel and atrasentan versus docetaxel and placebo for men with advanced castration-resistant prostate cancer (SWOG S0421): a randomised phase 3 trial

David I. Quinn, Catherine M. Tangen, Maha Hussain, Primo N. Lara, Amir Goldkorn, Carol M. Moinpour, Mark Garzotto, Philip C. Mack, Michael A. Carducci, J. Paul Monk,

The Lancet Oncology · 2013 · 159 citations · 36 references

Concepts

References

36